Has Bernadette Sisnorio received payments from drug or device companies?

Yes. Drug and device makers reported $10,171 in general payments to Bernadette Sisnorio across 485 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bernadette Sisnorio did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bernadette Sisnorio come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bernadette Sisnorio

Nurse Practitioner · Las Vegas, NVNPI 1073102653

Payments from drug & device makers

$10,171in general payments, 2019–2025

Across 485 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$4K
Novartis$1K
Pfizer$739
Neurocrine Biosciences, Inc.$706
Lundbeck LLC$584
Amgen$403
plus $3K from 38 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	161	$3,968
Novartis	71	$1,055
Pfizer	45	$739
Neurocrine Biosciences, Inc.	23	$706
Lundbeck LLC	23	$584
Amgen(2 entities)	19	$403
AstraZeneca(2 entities)	17	$331
UCB, Inc.	13	$278
Biohaven Pharmaceutical Holding Company Ltd.	19	$241
Genentech USA, Inc.	7	$127
Biohaven Pharmaceuticals, Inc.	3	$125
Takeda Pharmaceuticals U.S.A., Inc.	5	$116
Biogen	6	$108
Acadia Pharmaceuticals Inc	5	$106
Philips North America LLC	3	$104
Argenx US, Inc.	6	$103
Octapharma USA, Inc.	7	$103
SK Life Science, Inc.	5	$94
Ipsen Biopharmaceuticals, Inc	4	$79
Sanofi	3	$73
Sunovion Pharmaceuticals Inc.	5	$73
Otsuka America Pharmaceutical, Inc.	3	$64
Grifols USA, LLC	3	$57
Mallinckrodt Hospital Products Inc.	3	$57
Catalyst Pharmaceuticals, Inc.	2	$44
Johnson & Johnson	2	$41
Aucta Pharmaceuticals, Inc.	4	$40
Bristol Myers Squibb	2	$33
Merz Pharmaceuticals, LLC	1	$31
Alnylam Pharmaceuticals Inc.	1	$25
EMD Serono, Inc.	1	$25
Axsome Therapeutics, Inc.	1	$24
ANI Pharmaceuticals, Inc.	1	$22
TG Therapeutics, Inc.	1	$22
Teva Pharmaceuticals USA, Inc.	1	$21
Tanabe Pharma America, Inc.	1	$19
CSL Behring	1	$19
GRT US Holding, Inc.	1	$18
Avion Pharmaceuticals	1	$16
Avanir Pharmaceuticals, Inc.	1	$16
Neurelis, Inc.	1	$15
Medtronic	1	$15
Acorda Therapeutics, Inc	1	$15
Averitas Pharma Inc.	1	$15

How this compares

$10,171 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.

See all nurse practitioner providers in Nevada →

Medicare billing

Part B allowed, 2024

$33,418

Medicare patients

258

Services billed

358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Las Vegas

Vanessa AntolinLas Vegas$225K
Shannon SouthwickLas Vegas$85K
Melanie SpeedLas Vegas$80K
Shelley MilesLas Vegas$34K
Nasslynne LenzLas Vegas$32K
Bonnie KwanLas Vegas$30K
Amanda RalphLas Vegas$26K
Teodoro AgtayLas Vegas$25K
Katherine WhitmireLas Vegas$18K
Jennifer WalshLas Vegas$18K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →